Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MEDP On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMEDPMedpace$302.88+4.2%$314.64$250.05▼$459.77$9.16B1.46338,813 shs572,673 shsInvesting Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMEDPMedpace+4.00%+2.23%-6.67%-11.97%-23.82%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMEDPMedpace4.4291 of 5 stars3.12.00.04.62.65.01.3Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMEDPMedpace 2.23Hold$349.3015.33% UpsideCurrent Analyst Ratings BreakdownLatest MEDP Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/23/2025MEDPMedpaceTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$333.00 ➝ $300.004/23/2025MEDPMedpaceRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetNeutral ➝ Neutral$340.00 ➝ $313.004/22/2025MEDPMedpaceWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Market Perform4/14/2025MEDPMedpaceTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Hold$370.00 ➝ $328.004/10/2025MEDPMedpaceTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$347.00 ➝ $333.004/9/2025MEDPMedpaceMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$400.00 ➝ $355.003/24/2025MEDPMedpaceLeerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeHold3/24/2025MEDPMedpaceLeerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageMarket Perform$330.001/27/2025MEDPMedpaceRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$354.00 ➝ $362.00(Data available from 4/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMEDPMedpace$2.16B4.25$12.25 per share24.72$27.10 per share11.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMEDPMedpace$404.39M$13.1023.9822.173.8119.17%51.48%20.47%N/ALatest MEDP EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails4/21/2025Q1 2025MEDPMedpace$3.06$3.67+$0.61$3.67$528.38 million$558.57 million2/10/2025Q4 2024MEDPMedpace$2.96$3.67+$0.71$3.67$534.99 millionN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMEDPMedpaceN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMEDPMedpaceN/A0.930.93Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMEDPMedpace77.98%Insider OwnershipCompanyInsider OwnershipMEDPMedpace20.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMEDPMedpace5,20030.23 million24.28 millionOptionableMEDP HeadlinesRecent News About These CompaniesAnalysts Set Medpace Holdings, Inc. (NASDAQ:MEDP) PT at $357.50April 25 at 1:33 AM | americanbankingnews.comMedpace (NASDAQ:MEDP) Hits New 52-Week Low - Time to Sell?April 24 at 12:15 PM | marketbeat.comWilliam Blair Reaffirms "Market Perform" Rating for Medpace (NASDAQ:MEDP)April 24 at 10:45 AM | marketbeat.comEversept Partners LP Makes New Investment in Medpace Holdings, Inc. (NASDAQ:MEDP)April 24 at 7:09 AM | marketbeat.comMedpace price target lowered to $300 from $333 at TruistApril 23 at 6:29 PM | markets.businessinsider.comMedpace price target lowered to $313 from $340 at BairdApril 23 at 6:29 PM | markets.businessinsider.comMedpace (NASDAQ:MEDP) Issues Quarterly Earnings ResultsApril 23 at 4:51 PM | marketbeat.comMedpace (NASDAQ:MEDP) Issues FY 2025 Earnings GuidanceApril 23 at 4:51 PM | marketbeat.comWhy Medpace Holdings, Inc.’s (MEDP) Stock Is Down 5.57%April 23 at 8:27 AM | aaii.comBI Asset Management Fondsmaeglerselskab A S Sells 2,269 Shares of Medpace Holdings, Inc. (NASDAQ:MEDP)April 23 at 5:26 AM | marketbeat.comCanada Pension Plan Investment Board Has $14.45 Million Holdings in Medpace Holdings, Inc. (NASDAQ:MEDP)April 23 at 4:50 AM | marketbeat.comMedpace Holdings, Inc. (NASDAQ:MEDP) Receives Consensus Rating of "Hold" from AnalystsApril 23 at 2:23 AM | marketbeat.comMedpace Posts Strong Revenue Growth Amid Challenging Market ConditionsApril 22 at 9:23 PM | news.themarketisopen.comS&P 500 Futures Climb in Premarket Trading; Northrop Grumman, Medpace Holdings LagApril 22 at 9:23 PM | marketwatch.comMedpace Holdings, Inc. (MEDP) Q1 2025 Earnings Call TranscriptApril 22 at 9:23 PM | seekingalpha.comMedpace drops despite Q1 beat amid disappointing performance metricsApril 22 at 9:23 PM | msn.comMedpace to increase size of stock buyback program by $1BApril 22 at 9:23 PM | msn.comMedpace Holdings, Inc. 2025 Q1 - Results - Earnings Call PresentationApril 22 at 2:39 PM | seekingalpha.comMedpace reports Q1 EPS $3.67, consensus $3.08April 22 at 4:51 AM | markets.businessinsider.comMedpace raises FY25 EPS view to $12.26-$13.04 from $11.93-$12.69April 22 at 4:51 AM | markets.businessinsider.comMedpace Holdings, Inc. (NASDAQ:MEDP) Shares Sold by Guggenheim Capital LLCApril 22 at 4:06 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMEDP Company DescriptionsMedpace NASDAQ:MEDP$302.88 +12.34 (+4.25%) As of 04/24/2025 04:00 PM EasternMedpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Now Is the Time to Buy ServiceNow—The Rebound Is Real Seismic Shift at Intel: Massive Layoffs Precede Crucial Earnings Rocket Lab Lands New Contract, Builds Momentum Ahead of Earnings Netflix’s Trillion-Dollar Baby Ambition: Realistic or Ridiculous? Chip Giant ASML Gets New Price Targets With Big Upside Salesforce Is Ready to Rebound With Analysts Forecasting Upside What's Behind Bill Ackman Buying Hertz Stock? S&P 500 and Nasdaq-100 Flashed Death Crosses—Should You Worry? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
